4.5 Article

Two-Session Tumor and Retrogasserian Trigeminal Nerve-Targeted Gamma Knife Radiosurgery for Secondary Trigeminal Neuralgia Associated with Benign Tumors

Journal

WORLD NEUROSURGERY
Volume 96, Issue -, Pages 136-147

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.wneu.2016.08.082

Keywords

Gamma knife radiosurgery; Meningioma; Retrogasserian target; Secondary trigeminal neuralgia; Tumor-related trigeminal neuralgia

Funding

  1. Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2016R1C1B1012374]
  2. National Research Foundation of Korea [2016R1C1B1012374] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

Ask authors/readers for more resources

OBJECTIVE: To investigate gamma knife radiosurgery (GKS) for benign tumor-associated secondary trigeminal neuralgia (TN). METHODS: Between 2006 and 2015, 21 patients with secondary TN due to meningioma were treated using GKS. Their mean age was 56.5 +/- 12.2 years. The 50% isodose was 12.5 +/- 1.1 Gy for the first GKS for the meningioma. Retrogasserian targeting of the trigeminal nerve at 90 Gy with a 4-mm collimator was used for the second GKS. RESULTS: The pain duration until GKS was 1.9 +/- 1.9 years. The meningiomas were located in the cisternal space in 13 patients (56.5%) and involved the skull base in 8 patients (43.5%). The mean duration of follow-up was 3.7 +/- 2.7 years. The pain control outcome was a Marseilles Pain Scale (MPS) score of I to IV in 15 patients (71%) and a score of V in 6 patients (29%). For these latter patients, we performed a second GKS targeting the trigeminal nerve and resulting in MPS scores of I to IV. The tumor size did not increase in any patient and decreased by >10% in 12 (80%) of the 15 patients who were followed for at least 1 year. Trigeminal nerve visibility may improve after tumor shrinkage. Retrogasserian trigeminal nerve targets may be used even with invisible trigeminal nerves using Meckel's cave as an anatomic marker. CONCLUSIONS: Here we show the reproducible feasibility of a 2-session GKS procedure using higher radiation doses, the first dose to treat the tumor and the second to treat the trigeminal nerves using retrogasserian targeting.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available